series-c
Stage
2
Investors
About
Omnix Medical develops novel antimicrobial peptide-based antibiotics designed to treat infections caused by drug-resistant bacteria such as Acinetobacter baumannii.
Explore Omnix Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.